The paroxetine controversy: lessons for ketamine trials

Lancet Psychiatry. 2015 Dec;2(12):1057-8. doi: 10.1016/S2215-0366(15)00472-1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antidepressive Agents, Second-Generation / therapeutic use
  • Clinical Trials as Topic
  • Depressive Disorder / drug therapy
  • Double-Blind Method
  • Humans
  • Ketamine*
  • Paroxetine / therapeutic use*
  • Selective Serotonin Reuptake Inhibitors / therapeutic use

Substances

  • Antidepressive Agents, Second-Generation
  • Serotonin Uptake Inhibitors
  • Paroxetine
  • Ketamine